Newsfeeds - Spark Newswire

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

Today, 7:51 PM

Gainers Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by 34.4% to $2.81 during Thursday's after-market session. The market value of their outstanding shares is at $29.0 million.

ACOR

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 7:51 PM

ADTX

2 minute read

Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet

By Lisa Levin

Today, 7:51 PM

U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping by more than 3% on Monday.

APPH

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 7:51 PM

ABVC

4 minute read

70 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 7:51 PM

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.

ABVC

1 minute read

Why Hillstream BioPharma Shares Are Trading Higher Today?

By Vandana Singh

Today, 7:51 PM

Hillstream BioPharma Inc (NASDAQ:HILS) shares are trading higher after it authorized a share repurchase program to acquire up to $1 million in common…

HILS

5 minute read

79 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:51 PM

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.

ADTH

3 minute read

38 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 7:51 PM

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma Delta T cell allogeneic therapies.

ADTH